Profit After Tax grows 18.9% at ₹520 Crores for Q4 FY2024
PERFORMANCE FOR THE QUARTER AND YEAR ENDED MARCH 31, 2024
- Gross Direct Premium Income (GDPI) of the Company stood at ₹ 247.76 billion in FY2024 compared to ₹ 210.25 billion in FY2023, a growth of 17.8%, which was higher than the industry growth of 12.8%. Excluding crop and mass health, GDPI growth of the Company was at 17.1%, which was higher than the industry growth of 14.8% in FY2024.
- GDPI of the Company was at ₹ 60.73 billion in Q4 FY2024 as against ₹ 49.77 billion in Q4 FY2023, growth of 22.0%. This growth was higher than the industry growth of 9.5%. Excluding crop and mass health, GDPI growth of the Company was at 22.0%, which was higher than the industry growth of 13.8% in Q4 FY2024.
- Combined ratio stood at 103.3% for FY2024 compared to 104.5% for FY2023. Excluding the impact of CAT losses of ₹ 1.37 billion, the combined ratio was 102.5% in FY2024.
- Combined ratio stood at 102.2% in Q4 FY2024 as against 104.2% in Q4 FY2023.
- Profit before tax (PBT) grew by 21.0% to ₹ 25.55 billion in FY2024 as against ₹ 21.13 billion in FY2023 whereas PBT grew by 21.9% to ₹ 6.98 billion in Q4 FY2024 as against ₹ 5.73 billion in Q4 FY2023.
- Capital gains were at ₹ 5.51 billion in FY2024 compared to ₹ 4.53 billion in FY2023. Capital gains were at ₹ 1.56 billion in Q4 FY2024 as against ₹ 1.59 billion in Q4 FY2023.
- Consequently, Profit after tax (PAT) grew by 11.0% to ₹ 19.19 billion in FY2024 as against ₹ 17.29 billion in FY2023. Excluding impact of reversal of tax provision in Q2 FY2023, PAT grew by 19.8% in FY2024.
- PAT grew by 18.9% to ₹ 5.20 billion in Q4 FY2024 from ₹ 4.37 billion in Q4 FY2023.
- The Board of Directors of the Company has proposed final dividend of ₹ 6.00 per share for FY2024. The payment is subject to the approval of shareholders in the ensuing Annual General Meeting of the Company. The overall dividend for FY2024 including proposed final dividend is ₹ 11.00 per share.
- Return on Average Equity (ROAE) was 17.2% in FY2024 compared to 17.7% in FY2023. ROAE was 17.8% in Q4 FY2024 compared to 17.2% in Q4 FY2023.
- Solvency ratio was 2.62x at March 31, 2024 as against 2.57x at December 31, 2023 and higher than the minimum regulatory requirement of 1.50x. Solvency ratio was 2.51x at March 31, 2023.
Operating Performance Review
(₹ billion)
Financial Indicators | Q4 FY2023 | Q4 FY2024 | Growth % | FY2023 | FY2024 | Growth % | |
GDPI | 49.77 | 60.73 | 22.0% | 210.25 | 247.76 | 17.8% | |
PBT | 5.73 | 6.98 | 21.9% | 21.13 | 25.55 | 21.0% | |
PAT | 4.37 | 5.20 | 18.9% | 17.29 | 19.19 | 11.0%* |
Ratios
Financial Indicators | Q4 FY2023 | Q4 FY2024 | FY2023 | FY2024 |
ROAE (%) – Annualised | 17.2% | 17.8% | 17.7% | 17.2% |
Combined Ratio (CoR) | 104.2% | 102.2% | 104.5% | 103.3%** |
* Excluding the reversal of tax provision in Q2 FY2023, PAT grew by 19.8% in FY2024.
** Excluding the impact of CAT losses CoR was 102.5% for FY2024.